EuropaBio Industry Hearing

Search the site

Tissue Engineering Events

EuropaBio is organising an Industry Hearing on the new proposed EU wide rules for tissue engineering now being developed by the EU Commission. The hearing is timed to take place just after the major Business Conference on Tissue Engineering.

EuropaBio Industry Hearing

EuropaBio Industry Hearing on Tissue Engineering and Advanced Therapies

Radisson SAS Brussels – afternoon - 9November 2005

This Industry Hearing comprises two panel discussions - one with authorities and the other with stakeholders - to discuss EU framework rules for tissue engineering which is now being developed. Be heard by the EU Institutions responsible for this.

The hearing will give you an understanding of how the new proposed rules on tissue engineering will impact your business. The session will enable you to actively take part in and influence the EU rule making process on time.

Registration for the Industry Hearing is now closed

Price: €400 for non members * €300 for EuropaBio members and members of National Associations

Programme printer-friendly version available here (PDF)

1:00 pm	Registration
1:30 pm	Welcome address	Johan Vanhemelrijck Europabio Secretary General
PANEL I - THE AUTHORITIES
1:35 pm	The new proposed Regulation	Nicolas Rossignol DG Enterprise
1:50 pm	Comments from the Authorities Moderator: EMEA Patrick Celis, EMEA	Egbert Flory Head of Section Somatic Cell Therapeutics Paul-Ehrlich-Institut Eduardo Fernandez Zincke DG Sanco Stéphane Hogan Head of Unit, DG Research Peter Liese Member of the European Parliament Richard Woodfield, MHRA, UK Presidency
2:40 pm	Interactive Session – Q and A
3:00 pm: COFFEE BREAK
PANEL II - THE STAKEHOLDERS
3:20 pm	Comments from the Stakeholders Moderator: Heidi De Wit, Head of EuropaBio’s Advanced Therapies Working Group, Genzyme Corporate Affairs Europe	Detlef Niese Head External Relations Clinical Development and Medical Affairs Novartis Nancy Veulemans Clinical and Regulatory Affairs TiGenix Dario Pirovano Director Eucomed Fabrizia Bignami Eurordis Augustinus Bader European Tissue Engineering Society
4:10 pm	Interactive Session – Q & A
4:50 pm	Conclusions Invitation to join Technical Workshops	Andrea Rappagliosi Chair of EuropaBio’s Healthcare Council Vice President Serono
	5:00 pm: COCKTAIL

Conference

Conference and EuropaBio Industry Hearing:

"Tissue Engineering and Regenerative Medicine - Commercializing Future Life Saver"

Radisson SAS Brussels - 8 / 9 November 2005

Two day conference on marketing and business development strategies for tissue engineered products comprising interactive panel discussions and networking opportunities which includes access to the Industry Hearing

The speaker panel of 17 experts includes:

Duncan MacKay, Head of Regulatory Affairs for TEP in Europe, Genzyme Biosurgery
Kelvin Brockbank, President & CSO of Cell & Tissue Systmes, Inc., Vice President of Organ Recovery Systems, Inc.
Nancy Veulemans, Head R&D and Regulatory Affairs, TiGenix
Gareth W. Roberts, CEO, NovaThera Ltd.
and more...

Learn from real time case studies on:

Commercialization strategies for therapeutics based on living cells
Improving logistics in distribution and storage of TEP
Changes in regulatory framework for TEP within EU
Spheramine - cell therapy for Parkinson's disease, Case study about requirements and clinical program for obtaining market approval

Price: £1596 (GBP)

All conference delegates have a FREE ENTRY to EuropaBio Industry Hearing

back